Pharming Group (PHAR)
8.35
+0.49
(+6.23%)
USD |
NASDAQ |
Jun 28, 16:00
8.125
-0.22
(-2.69%)
After-Hours: 20:00
Pharming Group Accounts Receivable (Quarterly): 38.70M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 38.70M |
December 31, 2023 | 35.41M |
September 30, 2023 | 40.52M |
June 30, 2023 | 33.16M |
March 31, 2023 | 32.93M |
December 31, 2022 | 20.96M |
September 30, 2022 | 28.83M |
June 30, 2022 | 32.88M |
March 31, 2022 | 31.44M |
December 31, 2021 | 18.08M |
September 30, 2021 | 32.81M |
June 30, 2021 | 37.57M |
March 31, 2021 | 32.88M |
December 31, 2020 | 23.51M |
September 30, 2020 | 31.05M |
June 30, 2020 | 29.68M |
March 31, 2020 | 33.71M |
December 31, 2019 | 28.86M |
September 30, 2019 | 29.52M |
June 30, 2019 | 28.00M |
March 31, 2019 | 25.59M |
December 31, 2018 | 17.54M |
September 30, 2018 | 27.39M |
June 30, 2018 | 19.40M |
March 31, 2018 | 17.72M |
Date | Value |
---|---|
December 31, 2017 | 10.67M |
September 30, 2017 | 20.28M |
June 30, 2017 | 21.33M |
March 31, 2017 | 21.21M |
December 31, 2016 | 6.605M |
September 30, 2016 | 6.588M |
June 30, 2016 | 6.174M |
March 31, 2016 | 4.394M |
December 31, 2015 | 2.302M |
September 30, 2015 | 4.652M |
June 30, 2015 | 4.774M |
March 31, 2015 | 2.571M |
December 31, 2014 | 0.8524M |
September 30, 2014 | 2.115M |
June 30, 2014 | 1.775M |
March 31, 2014 | 0.8073M |
December 31, 2013 | 0.2914M |
September 30, 2013 | 0.6059M |
June 30, 2013 | 7.085M |
March 31, 2013 | 0.8593M |
December 31, 2012 | 0.00 |
September 30, 2012 | 1.270M |
March 31, 2012 | 1.549M |
December 31, 2011 | 0.4575M |
September 30, 2011 | 1.248M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
18.08M
Minimum
Dec 2021
40.52M
Maximum
Sep 2023
31.02M
Average
32.13M
Median
Accounts Receivable (Quarterly) Benchmarks
uniQure NV | 10.72M |
ProQR Therapeutics NV | -- |
Merus NV | 58.73M |
argenx SE | -- |
Pharvaris NV | -- |